The Economic Impact of Syncope: Direct and Indirect Costs
- 15 Downloads
In this chapter, we explore the economic impact of syncope and potential strategies to attenuate the burden. Syncope is a very common problem with an estimated yearly cost greater than $10 billion USD annually in the USA alone. Direct costs include costs of health care-delivery, while indirect cost includes the impact on patient and society such as loss of productivity and earning potential. Drivers of direct cost include the high admission rate, unnecessary tests utilization, and unexplained syncope. Decreasing both direct and indirect costs is contingent on obtaining an accurate diagnosis through a standardized approach informed by the guidelines. More advanced data methods such as machine learning, point-of-care software, telemedicine, and use of non-physician providers may also help further reduce cost, and expand cost-effective state-of-the-art syncope care in areas where it is much needed.
Conflict of Interest
- 3.Chen LY, Shen WK, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Prevalence of syncope in a population aged more than 45 years. Am J Med. 2006;119(12):1088.e1081–7.Google Scholar
- 10.Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients with Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2017;70(5):e39–e110.CrossRefGoogle Scholar
- 13.HCUPnet, Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality, Rockville, MD. https://hcupnet.ahrq.gov.